Company news
Vcanbio Cell & Gene Engineering Corp., Ltd. news in 2024
Vcanbio Cell & Gene Engineering Corp., Ltd.'s news releases, calls and decks from 2024, newest first.
Announcement on Using Temporarily Idle Raised Funds and Self-owned Funds for Cash Management
December 18, 2024
Announcement on the Progress of Drug Clinical Trials and Orphan Drug Qualification Accreditation by FDA for a Wholly-owned Subsidiary
December 16, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
November 18, 2024
Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2024
November 12, 2024
Notice on Convening the 2nd Extraordinary General Meeting in 2024
October 29, 2024
Announcement on Subsidiary's Signing of Supplementary Agreement to Commissioned R&D Service Contract
October 18, 2024
Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
September 25, 2024
Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2024
September 19, 2024
Announcement on Resolutions of the 13th Interim Meeting of the 11th Board of Directors
September 9, 2024
Announcement on Change of Lead Financial Advisor for Continuous Supervision
September 6, 2024